These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30274306)

  • 41. Duality of Iron Oxide Nanoparticles in Cancer Therapy: Amplification of Heating Efficiency by Magnetic Hyperthermia and Photothermal Bimodal Treatment.
    Espinosa A; Di Corato R; Kolosnjaj-Tabi J; Flaud P; Pellegrino T; Wilhelm C
    ACS Nano; 2016 Feb; 10(2):2436-46. PubMed ID: 26766814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
    Peifer M; Hertwig F; Roels F; Dreidax D; Gartlgruber M; Menon R; Krämer A; Roncaioli JL; Sand F; Heuckmann JM; Ikram F; Schmidt R; Ackermann S; Engesser A; Kahlert Y; Vogel W; Altmüller J; Nürnberg P; Thierry-Mieg J; Thierry-Mieg D; Mariappan A; Heynck S; Mariotti E; Henrich KO; Gloeckner C; Bosco G; Leuschner I; Schweiger MR; Savelyeva L; Watkins SC; Shao C; Bell E; Höfer T; Achter V; Lang U; Theissen J; Volland R; Saadati M; Eggert A; de Wilde B; Berthold F; Peng Z; Zhao C; Shi L; Ortmann M; Büttner R; Perner S; Hero B; Schramm A; Schulte JH; Herrmann C; O'Sullivan RJ; Westermann F; Thomas RK; Fischer M
    Nature; 2015 Oct; 526(7575):700-4. PubMed ID: 26466568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design of hybrid nanovehicles for remotely triggered drug release: an overview.
    Liu J; Detrembleur C; Mornet S; Jérôme C; Duguet E
    J Mater Chem B; 2015 Aug; 3(30):6117-6147. PubMed ID: 32262732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma.
    Fabian J; Opitz D; Althoff K; Lodrini M; Hero B; Volland R; Beckers A; de Preter K; Decock A; Patil N; Abba M; Kopp-Schneider A; Astrahantseff K; Wünschel J; Pfeil S; Ercu M; Künkele A; Hu J; Thole T; Schweizer L; Mechtersheimer G; Carter D; Cheung BB; Popanda O; von Deimling A; Koster J; Versteeg R; Schwab M; Marshall GM; Speleman F; Erb U; Zoeller M; Allgayer H; Simon T; Fischer M; Kulozik AE; Eggert A; Witt O; Schulte JH; Deubzer HE
    Oncotarget; 2016 Oct; 7(41):66344-66359. PubMed ID: 27572323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Silk Reservoirs for Local Delivery of Cisplatin for Neuroblastoma Treatment: In Vitro and In Vivo Evaluations.
    Yavuz B; Zeki J; Taylor J; Harrington K; Coburn JM; Ikegaki N; Kaplan DL; Chiu B
    J Pharm Sci; 2019 Aug; 108(8):2748-2755. PubMed ID: 30905702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.
    Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T
    Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MYCN concurrence with SAHA-induced cell death in human neuroblastoma cells.
    Cortés C; Kozma SC; Tauler A; Ambrosio S
    Cell Oncol (Dordr); 2015 Oct; 38(5):341-52. PubMed ID: 26306783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimized Photodynamic Therapy with Multifunctional Cobalt Magnetic Nanoparticles.
    Choi KH; Nam KC; Kim UH; Cho G; Jung JS; Park BJ
    Nanomaterials (Basel); 2017 Jun; 7(6):. PubMed ID: 28604596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma.
    Arnhold V; Schmelz K; Proba J; Winkler A; Wünschel J; Toedling J; Deubzer HE; Künkele A; Eggert A; Schulte JH; Hundsdoerfer P
    Oncotarget; 2018 Jan; 9(2):2304-2319. PubMed ID: 29416773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ability of circular extrachromosomal DNA molecules to carry amplified MYCN proto-oncogenes in human neuroblastomas in vivo.
    VanDevanter DR; Piaskowski VD; Casper JT; Douglass EC; Von Hoff DD
    J Natl Cancer Inst; 1990 Dec; 82(23):1815-21. PubMed ID: 2250296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.
    Keshelava N; Seeger RC; Groshen S; Reynolds CP
    Cancer Res; 1998 Dec; 58(23):5396-405. PubMed ID: 9850071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma.
    Mao Y; Eissler N; Blanc KL; Johnsen JI; Kogner P; Kiessling R
    Clin Cancer Res; 2016 Aug; 22(15):3849-59. PubMed ID: 26957560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma.
    Colicchia V; Petroni M; Guarguaglini G; Sardina F; Sahún-Roncero M; Carbonari M; Ricci B; Heil C; Capalbo C; Belardinilli F; Coppa A; Peruzzi G; Screpanti I; Lavia P; Gulino A; Giannini G
    Oncogene; 2017 Aug; 36(33):4682-4691. PubMed ID: 28394338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: potentiation by irradiation.
    Gong H; Pöttgen C; Stüben G; Havers W; Stuschke M; Schweigerer L
    Int J Cancer; 2003 Sep; 106(5):723-8. PubMed ID: 12866032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeted photo-chemo therapy of malignancy on the chest wall while cardiopulmonary avoidance based on Fe3O4@ZnO nanocomposites.
    Zhang H; Guo L; Ding S; Xiong J; Chen B
    Oncotarget; 2016 Jun; 7(24):36602-36613. PubMed ID: 27153557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stable knockdown of MYCN by lentivirus-based RNAi inhibits human neuroblastoma cells growth in vitro and in vivo.
    Jiang R; Xue S; Jin Z
    Biochem Biophys Res Commun; 2011 Jul; 410(2):364-70. PubMed ID: 21683062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A simple strategy for chemo-photothermal ablation of breast cancer cells by novel smart gold nanoparticles.
    Poursalehi Z; Salehi R; Samadi N; Rasta SH; Mansoori B; Majdi H
    Photodiagnosis Photodyn Ther; 2019 Dec; 28():25-37. PubMed ID: 31454714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroblastoma: Therapeutic strategies for a clinical enigma.
    Modak S; Cheung NK
    Cancer Treat Rev; 2010 Jun; 36(4):307-17. PubMed ID: 20227189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complete elimination of established neuroblastoma by synergistic action of gamma-irradiation and DCs treated with rSeV expressing interferon-beta gene.
    Tatsuta K; Tanaka S; Tajiri T; Shibata S; Komaru A; Ueda Y; Inoue M; Hasegawa M; Suita S; Sueishi K; Taguchi T; Yonemitsu Y
    Gene Ther; 2009 Feb; 16(2):240-51. PubMed ID: 18987675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multifunctional MoS
    Xu M; Zhang K; Liu Y; Wang J; Wang K; Zhang Y
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110551. PubMed ID: 31622812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.